ASTEX PHARMACEUTICALS, INC Accounts Receivable
ASTEX PHARMACEUTICALS, INC had Accounts Receivable of $1.11 million as of 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2013-08-09
- 2013-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $1.11M.
- 2013-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $924.00K.
- 2012-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $1.06M.
- 2012-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $880.00K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2013-06-30 | $1.11M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $924.00K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $1.06M 10-Q · filed 2013-08-09 |
| 2012-09-30 | $880.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $6.04M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $598.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $5.19M 10-K · filed 2013-03-18 |
| 2011-09-30 | $366.00K 10-Q · filed 2011-11-09 |
| 2010-12-31 | $615.00K 10-K · filed 2012-03-15 |